However, it has not been investigated whether the levels of soluble iRs correlate with the severity of liver disease in the course of CHC and whether successful antiviral treatment based on direct-acting antivirals (DAAs) affects their plasma levels. The gene discussed is IARS1; the disease is liver disorder.